Dashboard
Curated content

All companies

Job board
Funding rounds
Exits
Matching tool
Investment heatmap

Powered by

EIT Climate-KIC
European Union
dealroom.co

Contact
FAQ
Privacy

Companies
Adaptimmune
Team
Team

Adaptimmune

Develops therapies to treat cancer. Learn more

Launch date

2008

Employees

501-1000 people

Market cap

€258m

Enterprise valuation

€106m (Public information from Sep 2024)

Share price

$1.01 ADAP

Company register number 06456741

Milton England (HQ)

http://www.adaptimmune.com/

https://twitter.com/adaptimmune https://www.linkedin.com/company/adaptimmune/

View job openings

B2C
manufacturing
health
biotechnology

hard tech
biotechnology
horizon europe
biotech and pharma
spinout
oncology
verified unicorns and $1b exits
intellectual property
from $1b exit to zebra

Authorizing premium user...